Gastroesophageal Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update indicates a Phase 1/2 study of BHB810 in advanced gastric and GEJ adenocarcinoma, with the trial currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1 Study of the Safety and Tolerability of CTX-10726 [Phase 1]
Phase 1 study update on the safety and tolerability of CTX-10726, currently recruiting across gastroesophageal cancer, hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers [Phase 1]
This Phase 1 trial evaluates gevokizumab in combination with standard-of-care anticancer therapies for metastatic colorectal cancer, gastroe…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: PRO1107 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 PRO1107 trial in advanced solid tumors, including endometrial and ovarian cancers, has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
This completed clinical study uses a systems approach to identify immunotherapy biomarkers within the postoperative wound-healing microenvir…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients
A completed clinical trial investigates whether pretreatment emotional distress affects survival in patients receiving immunotherapy. It als…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy [Phase 3]
The PREACT Phase 3 trial comparing chemoradiotherapy versus chemotherapy followed by D2 gastrectomy and adjuvant chemotherapy for locally ad…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer [Phase 2]
Phase 2 study of DKN-01 in combination with tislelizumab, with or without chemotherapy, in gastric and gastroesophageal cancers was terminat…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Futibatinib in Patients With Specific FGFR Aberrations [Phase 2]
Taiho Oncology reports a Phase 2 trial of futibatinib in patients with FGFR aberrations across advanced cancers. The study (NCT04189445) was…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating cabozantinib in combination with pembrolizumab for metastatic gastric cancer and gastroesophageal cancer; results h…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Early IntraVenous Administration of Nutritional Support [NA]
The clinical trial evaluating early intravenous administration of nutritional support in patients with stomach cancer and gastroesophageal c…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer [Phase 2]
A Phase 2 study evaluating tusamitamab ravtansine in combination with ramucirumab for pretreated gastric or gastroesophageal cancer has been…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer [Phase 1]
Phase 1 safety and tolerability study of Claudiximab in patients with advanced gastroesophageal cancer has completed, reporting safety findi…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]
This clinical trial update reports the completion of a first-in-human Phase 1 study evaluating AZD8701 with or without durvalumab in adults …
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer [Phase 2]
A Phase 2 trial comparing nab-paclitaxel plus a PD-1 inhibitor versus nab-paclitaxel alone as second-line therapy in advanced gastric and ga…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer [Phase 2]
A Phase 2 study comparing Modified FOLFOX with or without nivolumab and ipilimumab versus FLOT with nivolumab in previously untreated advanc…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluated avelumab with chemoradiation for resectable stage II/III esophageal and gastroesophageal cancer; the study has c…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies [Phase 1]
A Phase 1 trial evaluating immunotherapy combinations in gastrointestinal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers [Phase 2]
Phase 2 trial evaluating APX005M in combination with concurrent chemoradiation for resectable esophageal and gastroesophageal junction cance…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies [Phase 2]
Phase II study evaluating lenvatinib with pembrolizumab in metastatic gastroesophageal and gastric cancer after prior therapies; study compl…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma [Phase 2]
A Phase 2 clinical trial update investigates fruquintinib in combination with SOX as neoadjuvant therapy for locally advanced gastric adenoc…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 [Phase 2]
Phase 2 trial evaluating abemaciclib with pembrolizumab in locally advanced unresectable or metastatic gastroesophageal adenocarcinoma was t…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma [Phase 1]
Phase 1 trial updating TAS-102 combined with irinotecan in second-line or higher gastric and gastroesophageal adenocarcinoma; study complete…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial assessing SHR-1210 in combination with capecitabine plus oxaliplatin or apatinib for advanced gastric cancer has comp…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1, Phase 2]
Results from a Phase 1/2 study of INCB001158 in combination with chemotherapy for solid tumors, including biliary tract cancer and colorecta…